Jhbp (Cy) Holdings Ltd.
Edding Genor Group Holdings develops and markets a diversified biopharma portfolio, including GB491 CDK4/6 breast‑cancer inhibitor, novel antibody candidates (GB261, GB263T, GB268), cardiovascular agent Vascepa, anti‑infectives Vancocin/Ceclor, and early‑stage siRNAs.
Headquarters: China (CHN)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Hospitals and Health Care
- Industry: Medical Practices
- HQ: Zhuhai
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.